These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22231978)

  • 1. [Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil].
    Vieira Neto L; Abucham J; Araujo LA; Boguszewski CL; Bronstein MD; Czepielewski M; Jallad RS; Musolino NR; Naves LA; Ribeiro-Oliveira Júnior A; Vilar L; Faria Mdos S; Gadelha MR
    Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):725-6. PubMed ID: 22231978
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil].
    Vieira Neto L; Abucham J; Araujo LA; Boguszewski CL; Bronstein MD; Czepielewski M; Jallad RS; Musolino NR; Naves LA; Ribeiro-Oliveira Júnior A; Vilar L; Faria Mdos S; Gadelha MR
    Arq Bras Endocrinol Metabol; 2011 Mar; 55(2):91-105. PubMed ID: 21584426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laboratory diagnosis of acromegaly].
    Rosário PW
    Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):723-4. PubMed ID: 22231977
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly.
    Peacey SR; Shalet SM
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):297-303. PubMed ID: 11471869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the response to treatment in acromegaly.
    Clemmons DR; Strasburger C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5289-91. PubMed ID: 15531471
    [No Abstract]   [Full Text] [Related]  

  • 6. Should we still use glucose-suppressed growth hormone levels for the evaluation of acromegaly?
    Colao A; Lombardi G
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1181-2. PubMed ID: 18390816
    [No Abstract]   [Full Text] [Related]  

  • 7. Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.
    Wijayaratne DR; Arambewela MH; Dalugama C; Wijesundera D; Somasundaram N; Katulanda P
    J Med Case Rep; 2015 Oct; 9():241. PubMed ID: 26514337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation protocol: acromegaly and its investigation.
    Duncan E; Wass JA
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):285-93. PubMed ID: 10435052
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: acromegaly--consensus, what consensus?
    Trainer PJ
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3534-6. PubMed ID: 12161470
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of acromegaly.
    Katznelson L
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S31-5. PubMed ID: 16023876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A consensus on criteria for cure of acromegaly.
    Giustina A; Chanson P; Bronstein MD; Klibanski A; Lamberts S; Casanueva FF; Trainer P; Ghigo E; Ho K; Melmed S;
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3141-8. PubMed ID: 20410227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University.
    Fukuda I; Hizuka N; Murakami Y; Itoh E; Yasumoto K; Sata A; Takano K
    Intern Med; 2001 Oct; 40(10):987-92. PubMed ID: 11688841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic tests and basal values for defining active acromegaly.
    Tzanela M
    Neuroendocrinology; 2006; 83(3-4):200-4. PubMed ID: 17047383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers of acromegaly: GH vs. IGF-I.
    Barkan AL
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S97-100. PubMed ID: 15135787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus on the change of criteria for cure of acromegaly during the last decade].
    Kovács GL; Dénes J; Hubina E; Kovács L; Czirják S; Góth M
    Orv Hetil; 2011 May; 152(18):703-8. PubMed ID: 21498158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostics and treatment of acromegaly - updated recommendations of the Polish Society of Endocrinology.
    Bolanowski M; Ruchała M; Zgliczyński W; Kos-Kudła B; Hubalewska-Dydejczyk A; Lewiński A
    Endokrynol Pol; 2019; 70(1):2-18. PubMed ID: 30843181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A follow-up of 130 patients with acromegaly in a single centre.
    Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK
    Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory DKA as first presentation of acromegaly and a potential role for continuous venovenous hemofiltration in its successful management.
    Mewawalla P; Jaiswal G; Moustakakis M; Sankaranarayanan N; Dasanu CA
    Conn Med; 2011 Aug; 75(7):405-7. PubMed ID: 21905534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society.
    ;
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3099-102. PubMed ID: 15240576
    [No Abstract]   [Full Text] [Related]  

  • 20. Criteria for cure of acromegaly: a consensus statement.
    Giustina A; Barkan A; Casanueva FF; Cavagnini F; Frohman L; Ho K; Veldhuis J; Wass J; Von Werder K; Melmed S
    J Clin Endocrinol Metab; 2000 Feb; 85(2):526-9. PubMed ID: 10690849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.